Global Active Implantable Devices Market 2017-2022 - $24.02 Billion Opportunity Analysis and Industry Forecasts Report -

DUBLIN--()--The "Active Implantable Devices Market - Global Opportunity Analysis And Industry Forecast (2017-2022)" report has been added to's offering.

The global active implantable devices market is expected to grow at a CAGR of 6.7% from 2017 to 2022 to reach USD 24.02 billion by 2022.

The rising need for faster, effective, and safer devices is growing rapidly, which is majorly fueling the growth of the market. In addition, major factors such as increasing burden of cardiovascular diseases, rising prevalence of neurological disorders, growing investment & funds to develop technologically advanced products, and expanded applications of neurostimulators are expected to drive the growth of this market.

However, stringent regulations for approvals & rising product recalls, high cost of implants, and unfavorable reimbursement scenario restricts the growth of the market to some extent. Further, increasing pricing pressure on market players poses a great challenge for the growth of this market.

Scope of the Report:

Market by Product:

  • Implantable Cardioverter Defibrillators
  • Transvenous Implantable Cardioverter Defibrillators
  • Biventricular Implantable Cardioverter Defibrillators
  • Dual-Chamber Implantable Cardioverter Defibrillators
  • Single-Chamber Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Implantable hearing devices
  • Neurostimulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulators

Market Insights


  • Increasing Burden of Cardiovascular Diseases
  • Rising Prevalence of Neurological Disorders
  • Growing Investments and Funds to Develop Technologically Advanced Products
  • Expanded Applications of Neurostimulators


  • Stringent Regulation for Approvals & Rising Product Recalls
  • Issues Related to the Use of Implantable Medical Devices
  • High Cost of Implants and an Unfavorable Reimbursement Scenario


  • Emerging Markets offer Significant Growth Opportunities


  • Increasing Pricing Pressure on Market Players
  • Lack of Skilled Professionals

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market insights

5. Active Implantable Devices Market, by Product

6. Active Implantable Devices Market, by Geography

7. Competitive Landscape

8. Company Profiles

  • Abbott Laboratories (U.S.)
  • BIOTRONIK SE & Co. KG (Germany)
  • Boston Scientific Corporation (U.S.)
  • Cochlear Limited (Australia)
  • LivaNova PLC (U.K.)
  • MED-EL (Austria)
  • Medtronic plc (Ireland)
  • Nurotron Biotechnology Co. Ltd. (China)
  • Sonova Holding AG (Switzerland)
  • William Demant Holding A/S (Denmark)

For more information about this report visit

Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900